APA (7th ed.) Citation

MK, H., E, B., CE, W., O, G., M, D., LR, A., . . . IF, H. (2015). Dendritic cell vaccination combined with temozolomide retreatment: Results of a phase I trial in patients with recurrent glioblastoma multiforme. Journal of neuro-oncology, 121(2), 319. https://doi.org/10.1007/s11060-014-1635-7

Chicago Style (17th ed.) Citation

MK, Hunn, et al. "Dendritic Cell Vaccination Combined with Temozolomide Retreatment: Results of a Phase I Trial in Patients with Recurrent Glioblastoma Multiforme." Journal of Neuro-oncology 121, no. 2 (2015): 319. https://doi.org/10.1007/s11060-014-1635-7.

MLA (9th ed.) Citation

MK, Hunn, et al. "Dendritic Cell Vaccination Combined with Temozolomide Retreatment: Results of a Phase I Trial in Patients with Recurrent Glioblastoma Multiforme." Journal of Neuro-oncology, vol. 121, no. 2, 2015, p. 319, https://doi.org/10.1007/s11060-014-1635-7.